title: Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
authors.forename: Christos
authors.initials: C
authors.lastname: Mantas
authors.forename: George
authors.initials: G
authors.lastname: Kalabokis
authors.forename: Panagiota
authors.initials: P
authors.lastname: Goulia
authors.forename: Athanasios
authors.initials: A
authors.lastname: Tourlakopoulos
authors.forename: Thomas
authors.initials: T
authors.lastname: Hyphantis
authors.forename: Venetsanos
authors.initials: V
authors.lastname: Mavreas
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000068882:Paliperidone Palmitate; D011569:Psychiatric Status Rating Scales; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D007555:Isoxazoles; D011743:Pyrimidines; D000068882:Paliperidone Palmitate